RCVA is now at .23 I got this newsletter and of course I didn't react quick enough. Just posting it here for those who wish to read it.
WALL STREET TECHNICALS
September 27, 2006
----------------------------------------------------------------
----------------------------------------------------------------
Note: our previous alert SYMBA $1.00 - (Symbollon Pharmaceuticals, Inc)
announced that it intends to seek regulatory guidance for IoGen
(TM) in Europe. The Company will request regulatory guidance
meetings with the regulatory authorities in the United Kingdom,
Germany and Holland.
This is a huge step in the final approval process for IoGen.
Keep this on your ticker.
________________________________________________________________________________________________________________________________
CHART ALERT
The debt collection stock sector has been hot!
A SLEEPER STOCK in this sector, we feel is poised for a move!
This is a otc stock that has a low float and recent excellent news!
Do your DD!
Low volume player with recent steady trading, this is now sitting on
a major support line. In the past week we have already seen this stock
hit its third highest volume day since RCVA has traded.
FLOAT ONLY! 2.2 Million
<chart>
Receivable Acquisition & Management Corporation
RCVA .13 NOW .17
Receivable Acquisition & Management Corporation specializes in acquisition and liquidation of performing, sub-performing and non-performing receivables. The Company outsources all its collections to specialists in the U.S. and United Kingdom. The Company funds its purchases with its own capital, special purposed vehicles and a fund. The Company is run by two individuals who are well-experienced in corporate finance and management of distressed receivables.
RECENT NEWS
* Purchases a $1.2 Million Portfolio in the United Kingdom
* Announces Net Income Increases 494 Percent for Quarter Ending June 30, 2006
* Purchases a Student Loan Portfolio Totaling $4.74 Million
* Purchases a Student Loan Portfolio Totaling $5.9 Million
* Purchases Performing Portfolio of Medical Receivables Totaling $5.5 Million (May 6, 2005)
* Paid $3.5 million for a $51 million portfolio (May 6, 2005)
They pay pennies on the dollar for these face value portfolios and thru process of collections negotiate payments from the debtors. Collecting just 20% of the face value can reap a ton of cash flow for RCVA.
PUT THIS ON YOUR TICKER!!! RCVA .13
-----------------------------------------------------------
-----------------------------------------------------------
AI
